Table 2.

Transmucosal flux of ⁵¹Cr-EDTA in ileal mucosa in Ussing chambers

	Colon cancer (n=8)	CD non-inflamed (n=5)	CD inflamed (n=4)
Vehicle  experiments	3.5 (1.0–5.0)	5.8 (2.7–7.7)	10 (6.0–17)*
C10  experiments	15 (9.8–28)	40 (36–48)*	9.0 (3.0–15)

Data are given for the period of exposure to vehicle or sodium caprate (C10) as median (25–75th interquartile range) of transmucosal flux of ⁵¹Cr-EDTA (pmol/cm²/h).

*Increased permeability compared with ileal mucosa from patients with colon cancer (Mann-Whitney, p<0.05).